[Federal Register Volume 67, Number 119 (Thursday, June 20, 2002)]
[Notices]
[Page 42058]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-15565]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated November 26, 2001, and published in the Federal 
Register on December 20, 2001, (66 FR 65744), Cedarburg Pharmaceuticals 
LLC, 870 Badger Circle, Grafton, Wisconsin 53024, made application by 
letter to the Drug Enforcement Administration (DEA) to be registered as 
a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
------------------------------------------------------------------------

    The firm will manufacture these controlled substances for another 
firm.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Cedarburg Pharmaceuticals, LLC to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated the company to 
ensure that the company's registration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic class 
of controlled substance listed above is granted.

    Dated: June 7, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-15565 Filed 6-19-02; 8:45 am]
BILLING CODE 4410-09-M